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Carotid artery stent fracture identification and
clinical relevance
Gioacchino Coppi, MD, Roberto Moratto, MD, Jessica Veronesi, MD, Emanuele Nicolosi, MD, and
Roberto Silingardi, MD, Modena, Italy
Background: This study was conducted to identify the prevalence, risk factors, and clinical relevance of carotid artery stent
fracture.
Methods: Commercially available carotid stents were implanted in this prospective, observational study that began in
January 2004. Indications included asymptomatic patients (stenosis >80%), symptomatic patients (stenosis >60%), and
ulcerated lesions (>50%). Stent integrity was assessed with plain radiography at 12 months. Data were analyzed in April
2009 on a series of 341 consecutive patients treated with carotid artery stenting with at least 12 months follow-up.
Results: Stent fracture prevalence was 3.4% at 12 months (95% confidence interval, 1.7%-6.1%). The median clinical
follow-up was 30 months (range, 12-64 months) for 323 eligible patients. Treatment included 23.6% of symptomatic
patients. According to univariate analysis, calcification type III increased the odds of stent fracture bymore than 4.5 times
(odds ratio [OR], 4.74; P .006) and angulation>45° increased the odds of stent fracture by 6.5 times (OR, 6.51; P
.008). Carotid stent cell type, stent length, and stent over-sizing were not correlated with stent fracture incidence. Stent
fracture was not associated with stroke (0%), transient ischemic attack (0%), or death (0%). Restenosis was significantly
associated with stent fracture (P< .001). Multivariate analysis evidenced that type III calcification (OR, 3.90; P .029)
and angulation >45° (OR, 4.69; P  .026) were important risk factors for carotid stent fracture.
Conclusions: Carotid stent fracture is a rare complication after CAS and is associated with vessel angulation, calcification,
and restenosis. In this series, fracture identification was independent of stroke, transient ischemic attack, and mortality.
(J Vasc Surg 2010;51:1397-405.)Immediate and late results of carotid artery stenting
(CAS) are progressively improving with patient selection,
endovascular techniques, and materials.1,2 The introduc-
tion of self-expandable stents was an important step for-
ward in the recent history of carotid artery stenting, with
increased sophistication in terms of conformability, flexibil-
ity, adaptability, radial strength, scaffolding, and precision
of the delivery system.3,4 Concurrently, stents implanted in
other anatomic districts began to demonstrate reduced
resistance under various stresses associated with restenosis
and stent fracture.5-7 A further consideration includes the
suggested hypothesis in the literature regarding various
ranges of voluntary movements to which the neck is sub-
jected, such as flexion and extension, anteroposterior and
rotation and compression,8-9 and involuntary movements
including deglutition10 and a strong pulsatile flow attrib-
uted to the vicinity of the carotid arteries to the heart.8-11
To verify if stents could also fracture at the carotid level,
a study of nonrandomized patient data was designed and
implemented at our center in January 2004. The protocol
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doi:10.1016/j.jvs.2010.02.009to evaluate implanted stent integrity included a plain radi-
ography examination at 12 months from the intervention.
This study, which to our knowledge is the largest study of
carotid stent fracture identification reported to date, was
designed to evidence the prevalence of carotid stent frac-
ture, risk factors, and clinical relevance.
METHODS
Patient initial assessment includes an echo-color duplex
scan. When indications for CAS treatment are found, a
computed tomography angiography (CTA) is requested to
study anatomic characteristics of the arch and the origin of
the supra-aortic vessel.
Patient inclusion and exclusion criteria. CAS inclu-
sion criteria at our hospital are based on anatomic and
clinical parameters. Asymptomatic patients (stenosis80%,
ulcerated lesions 50%) and symptomatic patients (steno-
sis60%, ulcerated lesions50%) are considered for CAS.
Anatomic criteria include arch type and suitable femoral
artery access. Bovine and normal arches (type I, II, and III)
are included; exceptions include stenosis in the brachioce-
phalic artery or at the origin of the left common carotid
artery (CCA) and calcification in the aortic arch. Patients
are considered for CAS when they are considered unsuit-
able for traditional surgery because of clinically significant
cardiac disease, severe pulmonary disease, contralateral la-
ryngeal nerve palsy, restenosis80% after carotid endarter-
ectomy (CEA), previous neck radiation exposure or radical
neck surgery, and high carotid bifurcation. There is no
maximum age threshold at our center, but patients aged
65 years who are suitable for surgery are preferably
treated with traditional surgery.
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American Symptomatic Carotid Endarterectomy Trial
(NASCET) criteria.12 Calcification is classified according
to the average density value in Hounsfield units (HU) of
the entire lesion subsected into 1-mm2 regions,13 as seen at
CTA: class I, 50 HU; class II, 51-130 HU; and class III,
130 HU. Vessel angulation is calculated according to the
angle between the axes of the CCA and the internal carotid
artery (ICA) at maximum intensity projection CTA recon-
struction (Fig 1). Ulcerated lesions were considered an
indentation, discontinuity, or erosion of the luminal surface
of a plaque, directly exposing a portion of the inner plaque
with circulating blood, according to echo-duplex scan im-
ages.
Patients are selected based on preoperative CTA, pri-
marily according to aortic arch assessment. Patient prepa-
ration includes the administration of double-antiplatelet
therapy. In election, the patient is prescribed a second
antiaggregant for 3 days before the procedure—aspirin
(100 mg/d), ticlopidine (500 mg/d), or clopidogrel (75
mg/d)—depending on the primary antiplatelet. In emer-
gency repairs, a loading dose of clopidogrel (300 mg/d) is
administered.
Patients are routinely admitted to this center 1 day
before the procedure and are examined with an echo-color
duplex scan done by a vascular surgeon to confirm calcifi-
cation, evaluate the contralateral ICA, measure the ipsilat-
eral ICA, external carotid artery (ECA) and CCA, and
determine patency of the ipsilateral ECA.
The echo-duplex and CTA assessments are used to plan
Fig 1. Measurement of the carotid arterial angle between the axes
of the common carotid artery and the internal carotid artery (ICA)
as taken from a maximum intensity projection computed tomog-
raphy angiography 2D reconstruction (patient 7, Table IV).stent type and sizing; more flexible open-cell stents arepreferred in case of ICA tortuosity or class III calcification,
or both. In cases of class I and II calcification, more rigid,
closed-cell stents are used in vessels with angulation of
45°, and hybrid-cell stents are used for vessels with angu-
lation 45°.
CAS procedure. All procedures were completed by
one of two highly specialized CAS vascular surgeons. Per-
cutaneous access was obtained through the common fem-
oral artery. Intraoperative angiography of the aortic arch
was not performed because the morphologic information
was already available from the preoperative CTA, thus
reducing patient exposure to contrast medium and manip-
ulation of the aortic arch. A cerebral protection device was
used in all cases.
Predilation was performed after cerebral protection
device deployment only in the cases of severe stenosis with
type III calcification using a coronary balloon of 2.5, 3, or
3.5 mm.
Our protocol included the use of self-expanding, niti-
nol stents (stainless steel stents were also used at the initial
stages of the study) chosen according to a 1- to 2-mm
over-sizing with respect to the native vessel diameter, with
stent lengths of 30 or 40mm (maximum length available to
our center) and diameters of 6 to 12mm. Stents used in this
study included the X-act (Abbott Vascular, Redwood City,
Calif), Vivexx (CR Bard, Murray Hill, NJ), Acculink (Abbott
Vascular), Conformexx (BARD/Angiomed, Karlsruhe, Ger-
many), Vascuflex (B. Braun Medical, Boulogne Cedex,
France), Precise (Cordis, Miami Lakes, Fla), Protege (ev3
Endovascular Inc, Plymouth, Mass), Cristallo Ideale Ca-
rotid Stent System (Invatec, Roncadelle, Italy), and Wall-
stent (Boston Scientific, Natick, Mass). In the cases of
lesions 40 mm, double stents were implanted with an
overlapping of 2 to 5 mm according to the length of the
lesion. Double stenting was used for longer lesions only
and not for stent scaffolding reinforcement.
Post dilation was most commonly performed with a
5-  20-mm balloon (range, 4-6 mm).
A final intracranial and extracranial angiography was
routinely performed for stent patency assessment and even-
tual residual stenosis (20% is accepted).
Follow-up protocol. The CAS follow-up protocol
included the continuation of the double antiplatelet ther-
apy for 4 weeks, followed by permanent single antiplatelet
therapy. An echo-color duplex scan was performed at hos-
pital discharge, at 1, 6, and 12 months, and annually
thereafter. A plain cervical radiography was performed at 12
months in two projections (anteroposterior and laterolat-
eral) irrespective of clinical symptoms or physical findings.
All images were independently assessed by two vascular
surgeons and a radiologist.
In the case of stent fracture identification, treatment
selection was based on vessel anatomy and the evaluation of
restenosis severity. Symptomatic patients were treated in-
dependently of the restenosis rate and according to ana-
tomic indications. Asymptomatic patients were treated only
if restenosis 80%. Patients with an inferior restenosis
aTwo-sided Fisher exact test.
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echo-color duplex scan every 6 months.
Outcome and complication definitions. Stent frac-
ture types proposed by the Cardiovascular Institute of the
South (CIS), as reported by Ling et al,8 were used. Type I
involves a single strut fracture, type II is a multiple stent
fracture located at different sites, and types III and IV are
complete linear transverse fractures, respectively, without
and with stent displacement. Stent fracture location was
described as being in the proximal, middle, or distal seg-
ment of the stent.
Restenosis was classified according to the criteria pro-
posed by Lal et al,14 consisting of residual stenosis 20% to
50% (peak systolic velocity [PSV] 150 cm/s; ICA/CCA
ratio2.15), in-stent restenosis50% to 80% (PSV220
cm/s; ICA/CCA ratio 2.7), and in-stent restenosis
80% (PSV 340 cm/s; ICA/CCA ratio 4.15). Resteno-
sis at this center requiring reintervention was considered
80%.
Transient ischemic attack (TIA) was defined as any new
neurologic focal event with complete recovery 24 hours.
Stroke was defined as any neurologic event persisting for
24 hours. This study subclassified stroke according to
Table I. Patient demographic and anatomic preoperative
data for the study population divided according to the
identification of stent fracturea
Variable
No stent
fracture
With stent
fracture Pb
Patients, No. 312 11
Age, mean SD, y 73.7  7.3 74.8  5.9 .5
Gender, No. (%) .5
Male 231 (74) 9 (82)
Female 81 (26) 2 (18)
Hypertension, No. (%) 117 (57) 8 (72) .367
Smoking, No. (%) 158 (51) 6 (55) .5
Dyslipidemia, No. (%) 116 (38) 6 (55) .344
Ischemic heart disease,c
No. (%) 113 (37) 4 (36) .5
Preirradiation exposure,
No. (%) 0 (0) 1 (9) .034
Restenosis after CEA 18 (6) 1 (9) .496
Symptomatic, No. (%) 85 (27) 0 (0) .041
Contralateral occlusion,
No. (%) 33 (11) 2 (18) .339
Bilateral carotid stent,
No. (%) 16 (5) 0 (0) .5
Calcification, No. (%) .034
I 89 (28) 2 (18)
II 161 (52) 3 (27)
III 62 (20) 6 (55)
Angulation, No. (%) .028
45° 292 (94) 8 (73)
45° 18 (6) 3 (27)
CEA, Carotid endarterectomy; SD, standard deviation.
aFor continuous variables we applied the Kruskal-Wallis test. For categoric
covariates we applied the Fisher exact test.
bAll P values are two-sided.
cAngina, acute miocardial infarction, coronary artery by pass graft, percuta-
neous transluminal coronary angioplasty.consequences as fatal (direct or indirect cause of death),Table II. Operative data according to identification of
stent fracture
Variable
No stent
fracture
With stent
fracture
PaNo. (%) No. (%)
Patients, No 312 11
Predilation 1 (0.3) 1 (9) .068
Stents used 334 11 .5
Single 312 (93) 11 (100)
Double 22 (7) 0 (0)
Stent cell type .267
Closed cells 194 (58) 6 (55)
X-Act stent 167 6
Carotid Wallstent 27
Open cells 119 (36) 3 (27)
Vivexx 83 3
Acculink 17
Vascuflex 2
Conformexx 8
Precise 5
Protege 4
Hybrid cells 21 (6) 2 (18)
Cristallo 21 2
Total stent length .5
Short (30-mm) 98 (31) 2 (18)
Long (40-mm) 214 (69) 9 (82)
Postdilation 312 (100) 11 (100)
Oversizing
1 mm (n  181) 176 (97) 5 (3) .342
2 mm (n  142) 136 (96) 6 (4)Table III. Late complications, mortality, and restenosis
throughout the follow-up period according to
identification of stent fracture
Complications, No. (%)
No stent
fracture
With stent
fracture
PaNo. (%) No. (%)
Neurologic complications
(30 d) 2 (1) 0 (0) .5
Disabling stroke 1
Nondisabling Stroke 1
Reintervention (re-PTA) 1 1b .5
Conversion 1 .5
Mortality (12 mon) 7 (2) 0 (0) .5
Contralateral stroke 2
Ruptured AAA 1
Cancer 2
Respiratory insufficiency 1
Unknown 1
Restenosis, % .001
20 298 (96) 7 (64)
20-50 9 (3) 0 (0)
50-80 4 (1) 2 (18)
80 1 (1) 2 (18)
AAA, Abdominal aortic aneurysm; re-PTA, repeat percutaneous translumi-
nal angioplasty (redilation and restenting).
aTwo-sided Fisher exact test.
bRestenting and dilation (balloon size, 4.5-  30-mm  5-  20-mm)
before stent identification; final angiography did not identify stent frac-
ture.
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days after event, with an increase of 2 points or more over
the prestroke score), or nondisabling.15
Statistical analysis. An exploratory analysis was per-
formed using the Fisher exact test and the Mann-Whitney
test to compare categoric and continuous covariates in
univariate analysis, respectively. Data were updated at April
30, 2009. We also performed a univariate and multivariate
analysis that took into account only the baseline and oper-
Table IV. Demographic, anatomical, operative, 30 day co
stent fracture
Pt
Age
(y)
Sex,
(M/F)
Calcification
severity
(Angio-CT)
Ang
(deg)
Predilation,
balloon size
( 20 mm) Stent, c
1 82 M III 50 — X-act, cl
2 63 M III 80 — Cristallo
3 79 F III 20 2.5 X-act, cl
4 74 M II 45 — Vivexx, o
5 76 M I 20 — Vivexx, o
6 77 F III 20 — Cristallo
7 82 M III 60 — Vivexx, o
8 74 M III 40 — X-act, cl
9 77 M II 40 — X-act, cl
10 70 M I 20 — X-act, cl
11 68 M II 15 — X-act, cl
Ang, Angulation; CT, computed tomography; EPD, embolic protection
protection device (Invatec).
aIntraoperative neurological complication at initial CAS.
Table V. Fracture types, reinterventions and complication
Pt
Fracture
typeb
Follow-up from
CAS to fracture
identificationc
(month)
Mode of fracture
identification
Stent
fractur
locatio
(segmen
1 1 18 PR Proxim
2 2 12 PR Proxim
3 3 24e PR Middle
4 2 12 PR Proxim
5 2 12 PR Middle
6 1 12 PR Proxim
7 3 12 PR Proxim
8 3 12 PR Middle
9 3 6 PRd Proxim
10 4 4 Intra-op angiography
for contra-lat CAS
procedure
Middle
11 4 12 PR Middle
Mean 12.4
CAS, Carotid angioplasty and stenting; CCA, common carotid artery; ICA
aNo patients presented neurologic symptoms related to stent fracture.
bNitinol stent fracture according to the classification proposed by Cardiova
cFrom intervention to identification of stent fracture.
dPlain radiography performed at 12 months after primary contralateral CAS
e12 month plain radiographic follow-up was not performed.ative data of the patients. Considering the low frequency ofthe event under study, and the possible presence of the
phenomenon of monotone likelihood (nonconvergence of
likelihood function), the univariate and multivariate analy-
sis were performed using the logistic regression with Firth’s
penalized likelihood.16
Because the study was a prospective observational
study, we did not plan a sample size. All P values were based
on two-sided testing and a cutoff of .05 was considered to
demonstrate a moderate strength against the null hypoth-
cations and reinterventions for individual patients with
e EPD
Postdilation,
balloon size
(20, mm) 30-day compl.
Reintervention
before
identification
(month)
Em. Pro 5 — Redilation for
restenosis
80% (10)
rid Em. Pro 5.5 — —
Em. Pro 4.5 Disabling strokea —
Mo. Ma 5 — —
Mo. Ma 5 — —
rid Mo. Ma 5 — —
Mo. Ma 5 — —
Em. Pro 5 — —
Mo. Ma 5 — —
Em. Pro 5 — —
Em. Pro 4.5 — —
; Em. Pro, Emboshield Pro (Abbot Vascular); Mo.Ma, Mo. Ma embolic
patients with stent fracturea
ollow-up from
fracture
dentification
(month)
Restenosis (at
most recent
follow-up) %
Reintervention
after fracture
identification
(month)
Late complications
after fracture
identification
(month)
20 80 — Ipsilateral carotid
artery occlusion
asympt (26)
5 20-50 — —
18 20-50 — —
4 20-50 — —
12 20 — —
4 20-50 — —
1 20 — —
2 20 — —
14 20-50 — —
25 80d CCA-ICA
bypass in
PTFE (10)
—
36 20-50 — —
12.8
nal carotid artery; PR, plain radiography; PTFE, polytetrafluoroethylene.
Institute of the South (CIS) also applicable to carotid stents.
nths prior.mpli
ell typ
osed
, hyb
osed
pen
pen
, hyb
pen
osed
osed
osed
osed
devices of
e
n
t)
F
i
al
al
al
al
al
al
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6 moesis and provide clinically useful advice.
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During the study period, 341 consecutive patients were
treated for carotid artery stenosis with CAS after signed,
informed consent. During this same period, 577 patients
were treated with CEA. At 12 months, 18 patients had
been lost to radiographic follow-up, leaving 323 eligible
patients for the study. Patient demographic details and
comorbidity conditions are represented in Table I. Data are
divided according to the event of carotid stent fracture in all
patients treated with CAS during the study period.
Plain radiography identified 11 stent fractures. The
prevalence of stent fractures in the sample under study was
3.4% at 12 months (95% confidence interval [CI], 1.7%-
6.1%). Themedian clinical follow-up was 30months (range
12-64 months). Stent fracture was not detected in any
symptomatic patients as classified at initial CAS. Preirradia-
tion exposure (P  .034), calcification (P  .034), and
angulated vessels 45° (P  .028) were associated with
stent fracture, according to the Fisher exact test.
Operative data are reported in Table II. There were no
significant differences in the operative procedures accord-
ing to the event of stent fracture, including predilation (P
.068), cell type (P  .267), or stent length (P  0.5).
Over-sizing of 1 or 2 mm did not significantly influence the
incidence of stent fracture (P  .342) in this series.
Table III reports late stroke and TIA complications,
reinterventions, mortality, and restenosis throughout the
follow-up period. Results show that stroke/TIA (P  .5)
and mortality after 12 months (P .5) were not associated
with stent fracture. However, stent fracture was signifi-
cantly associated with restenosis (P .001). Five patients in
this series currently have restenosis 50% without stent
fracture.
For the 11 patients with stent fracture, Table IV reports
individual preoperative, operative, and follow-up data
before fracture identification. Table V reports individual
fracture types, fracture location, time to fracture identifica-
tion, and postidentification follow-up (average, 12.8
months). None of the patients with stent fracture experi-
enced a stroke or TIA related to stent fracture.
Patient 1 had previously been treated contralaterally
with CEA. The patient remained asymptomatic, but an
ipsilateral restenosis was identified at 6 months by echo-
duplex scan and was treated at 10 months with repeat
dilation. Plain radiography at 18 months showed a type 1
stent fracture, and a routine echo-duplex scan at 26months
identified a complete ipsilateral occlusion that was con-
firmed at CTA. The patient was asymptomatic and remains
stable at 34 months.
Patient 3 was preoperatively diagnosed with a type III
calcification in a 20° angulated vessel. A predilation was
performed and a closed-cell stent was chosen. This was the
only patient with a neurologic complication (intraoperative
at initial CAS).
Patient 10 had been exposed to radiation therapy be-
fore any carotid intervention. At the initial CAS (right
ICA), the left ICA stenosis was classified as 50%. An echo-duplex scan at 4 months showed the left ICA stenosis had
progressed rapidly to 80%. This was subsequently treated
with CAS. Intraoperative angiography during this proce-
dure showed a type 4 stent fracture of the right ICA
without restenosis (Fig 2). At 10 months, restenosis of the
right side was 80% (echo-duplex scan) and given the stent
fracture, a CCA-ICA bypass with a polytetrafluoroethylene
graft was performed. Restenosis was seen at 11 months in
the left ICA and was treated with a repeat dilation and
stenting.
Risk factors were analyzed by a univariate and multivar-
iate analysis (Table VI). Type III calcification increased the
odds for a stent fracture by 4.74 times (95% CI, 1.47-15.2;
P  .006), and an angulation of 45° increased the odds
by 6.51 times (95%CI, 1.72-24.6, P .008). Both of these
factors were also significant in a multivariable analysis, with
ORs of 3.90 (P .029) and 4.69 (P .026). Figs 1, 3, and
4 illustrate these associations. Severe calcification (type III
vs type I-II, P  .006) and angulation 45° (P  .008)
were associated with stent fracture according to Firth’s
penalized likelihood.
DISCUSSION
To our knowledge, this is the largest reported study to
date for stent fracture identification in carotid arteries.
Carotid stent fracture is making a place in the surgical
literature, along with stents implanted in other anatomic
districts.17-26 Much of the information regarding carotid
stent fracture has come from case reports9-11,27-30 and
smaller single-center experiences.8,31 As such, prevalence
Fig 2. Intraoperative angiography during carotid stenting for the
contralateral artery shows evidence of a type 4 stent fracture
(arrow) treated with a tapered X Act 8 to 10- 40 mm closed-cell
stent in a patient with preirradiation exposure.and clinical implications are yet to be confirmed.
eous
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fractures in various districts, our team decided to investi-
gate possible stent fractures at the carotid level. Given that
the echo-duplex scan does not allow complete visualization
of the stent structure,11 our protocol included plain radi-
ography at 12 months of follow-up. This study method was
chosen due to its simplicity of execution and organization
for a large patient population, relatively low costs, andmost
importantly, reduced patient radiation exposure. Many au-
thors have noted the difficulty of identifying and confirm-
ing carotid stent fracture during this study period, and a
fracture prevalence of 1.9% to 29% has been reported.8,31
In our experience and also noted by Ling et al,8 the
radiologic image has an undefined sensitivity and specificity
even at magnified levels. This phenomenon is especially
important with open-cell stents, with the possible mislead-
ing “fish scale” appearance.31 Deformation of the stent was
often evidenced at the location of calcification or the natu-
ral angle of the vessel. Some seemed compressed by the
obstructive matter and others seemed distorted by the
angle; the obtuse angle seemed to have the cells excessively
extended, rendering areas of the vessel unprotected, and
the acute angle seemed to have the stent structure folded in
on itself. Stent fracture for the open-cell stent could be best
evaluated by counting the bridge wires, but this would be
very complex owing to overlapping at the acute angle.
Other study methods, such as CTA, could give more accu-
rate information, but a detailed cost/benefit analysis would
be required before CTA could be recommended as a sur-
veillance examination for stent fracture.
In this series, patient classification as symptomatic at
initial CAS (preoperative stroke or TIA) was not associated
with stent fracture. A possible explanation may be that
Table VI. Univariate and multivariate analysis with Firth’
operative parameters and of the event of a stent fracture
Variable
Univariat
OR (95% CI)
Age 1.02 (0.94-1.10)
Female gender .74 (0.18-3.04)
Hypertension 1.81 (0.51-6.42)
Smoking 1.13 (0.36-3.59)
Dyslipidemia 1.96 (0.69-7.15)
Ischemic heart diseaseb 1.04 (0.32-3.42)
Diabetes mellitus 1.59 (0.44-5.97)
Restenosis after CEA 2.25 (0.38-13.2)
Symptomatic .11 (0.01-1.96)
Plaque type, 4-5 vs 0-3 16.0 (4.74-54.1)
Bilateral carotid stent .78 (0.05-13.8)
Contralateral occlusion 2.19 (0.52-9.25)
Calcification, III vs I-II 4.74 (1.47-15.2)
Cells type, hybrid-open 1.23 (0.38-3.90)
Stent length, long 1.49 (0.36-6.15)
Angulation 45° 6.51 (1.72-24.6)
CI, Confidence interval; CEA, carotid endarterectomy; OR, odds ratio.
aAll P values are two-sided.
bAngina, acute miocardial infarction, coronary artery by pass graft, percutanneurologic symptoms are often connected with noncalci-fied plaque types. Nandalur et al32 suggest that calcification
causing stenosis is significantly less likely to be symptomatic
and thus may be more stable than plaque without calcifica-
tion.
A strong association between restenosis and stent frac-
ture (P .001) was found in this series. A cause-and-effect
relationship cannot be deduced from this study because it is
uncertain whether the stent fracture causes restenosis or
vice versa. Restenosis 50% was evidenced in five patients
without stent fracture. Conversely, seven patients with
stent fracture had restenosis 20%. A recent review of
literature that included 4185 patients33 reported an in-
stent restenosis of70% to 80% at 24 months of about 4%,
and the authors expected that future incidences of resteno-
sis 80% may occur. Currently, two patients have stent
fracture and a restenosis rate of 50% to 80%. These
patients are being strictly maintained at close follow-up.
Two stent fractures were incidentally identified before
the 12-month suggested surveillance schedule according to
this center’s protocol. All patients were asymptomatic at
stent fracture identification, apart from patient 3, who was
symptomatic after the initial CAS and has remained neuro-
logically stable. The follow-up protocol at this center in-
cludes echo-duplex scanning at 1 and 6 months, therefore
patients are maintained under surveillance for possible re-
stenosis, which has been found to be associated with stent
fracture (P  .001).
Multivariate analysis identified type III calcification
(P  .029) and an angulation of 45° (P  .026) as statis-
tically significant risk factors. A possible explanation could
be that the presence of calcification along the stented vessel
generates continuous pressure at a specific segment of the
stent. As a consequence, the artery is rendered more rigid
istic regression analysis between comorbidity and
Multivariate
Pa OR (95% CI) P
.664 — —
.674 — —
.357 — —
.836 — —
.254 — —
.950 — —
.475 — —
.370 — —
.153 — —
.001 — —
.866 — —
.254 — —
.006 3.90 (1.17-12.9) .029
.729 — —
.578 — —
.008 4.69 (1.17-18.7) .026
transluminal coronary angioplasty.s log
eand more stress is transferred proximally and distally to
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increases, as does the likelihood of stent fracture.8
To our knowledge, this is the first single-center experi-
ence to significantly prove the association between vessel
angulation and severe calcification with carotid stent frac-
ture. Given this increased requirement for flexibility, we
prefer to use open-cell stents in cases of heavily calcified
Fig 3. The association of vessel angulation and calcification with
stent fracture. A, A type 1 stent fracture treated with a tapered
X-Act 7 to 9-  40-mm closed cell stent (patient 1, Table IV). B,
Preoperative maximum intensity projection computed tomogra-
phy angiography reconstruction for the same patient illustrates a
common carotid artery-internal carotid artery angulation (50°)
and type III calcification.plaque or vessel tortuosity (45°), with minimal stentover-sizing and without over postdilation. The calcified
plaque, as we have found in this study, can provoke stent
fracture in closed-cell stents, which may be connected to
stent rigidity. The open-cell stents are more flexible and
allow improved adaptability to the plaque mass. Bosier et
al4 suggests the opposite stent selection rationale, basing
stent selection on the advantage of the high radial force
associated with closed cells. At our center, closed-cell stents
are used for high emboligenic risk plaque types for im-
proved plaque coverage.
This series highlights a relatively low prevalence of
stent fracture of 3.4% at 12 months of follow-up (95%
CI, 1.7%-6.1%) and a low associated clinical relevance in
accordance with other studies dedicated to stent frac-
ture.8-9,11,28,30-31 Stent fracture was associated with two
reinterventions caused by restenosis, one before (redilation,
patient 1) and 1 after fracture detection (CCA–ICA by-
pass). Reintervention before fracture identification may
have weakened the stent integrity and contributed to the
subsequent stent fracture. Patient 10 had previously been
exposed to radiation at the neck, which induces an inflam-
matory reaction, thickening of the arterial wall, and in-
creases the risk of plaque formation,34 potentially further
stressing the stent integrity.
In light of current information and possible future
complications, we have decided to extend our study to
include plain radiography examinations annually in all pa-
Fig 4. Further evidence of the association of vessel angulation
and calcification is shown with a type 3 stent fracture treated,
treated at initial CAS with a tapered Vivexx 7 to 10-  40-mm
open cell stent (Pt 7, Table IV). See Fig 1 for the preoperative
maximum intensity projection computed tomography angiogra-
phy 2D reconstruction which illustrates a common carotid artery-
internal carotid artery angulation of 60° and a type III calcification
of the same patient.tients irrespective of symptoms. Despite incidental identifi-
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June 20101404 Coppi et alcation before 12 months in two patients, given the neuro-
logic stability of all patients associated with stent fracture
and intermediate surveillance for restenosis, this center will
continue its first radiographic examination at 12months. In
cases of restenosis50% throughout the follow-up period,
we recommend plain radiographic examinations for possi-
ble stent fracture identification.
This study is limited by unknown stent integrity in 5.3%
(18 of 341 patients either refused or were lost to radiologic
follow-up) of the CAS population treated at least 12
months before the data analysis date. Surveillance was
further limited by the sole use of plain radiography. If
alternative examination techniques such as CTA had been
used, the incidence rate might have been different.
CONCLUSIONS
The prevalence of stent fracture identified at plain
radiography in two projections is low. This prevalence may
be underestimated, and more sophisticated modes of eval-
uation of stent integrity could give us further information.
The presence of angulation and calcification significantly
augment the risk of stent fracture. In the follow-up period,
restenosis has also been associated with stent fracture. In
this series, stent fracture identification was independent of
stroke or TIA. More research is needed to study the evolu-
tion of this phenomenon into the long-term, and a com-
parative study of available surveillance methods in carotid
artery treatment for fracture identification is required.
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